The status of the choriocapillaris may be a valuable factor when monitoring the macular microvasculature in prediabetes and ...
Jonathan Gloth, MD, discusses how a dual Tie2/VEGF mechanism could reduce injection burden and the consequences of missed ...
Two optical treatment modalities have accumulated the strongest evidence base for slowing pediatric myopia progression ...
John W. Kitchens, MD, discusses patient selection for geographic atrophy treatment, counseling approaches, and emerging ...
Zhang traced growing interest in home tonometry back to the COVID-19 pandemic, when clinicians needed new ways to track patie ...
João Pedro Marques, MD, PhD, on how systematic reanalysis moved a cohort's solved rate from 59.4% to 70.1% and what it means ...
Dante Pieramici, MD, of California Retina Consultants, framed the sustained-delivery tyrosine kinase inhibitor (TKI) EYP-1901 ...
Jonathan Gloth, MD, explains how MK-8748's dual Tie2 agonist/VEGF inhibitor mechanism differs from VEGF blockade alone, and ...
Vitreoretinal specialist Dante Pieramici, MD, of California Retina Consultants breaks down the phase 3 COMO and CAPRI trials ...
A former US Navy flight surgeon turned three-time CMO, David J. Tanzer, MD, ABO, reflects on a career built at the pharma-clinic bridge.
Amy Zhang, MD, associate clinical professor in the glaucoma service at the Kellogg Eye Center, University of Michigan, spoke with Ophthalmology Times about the ergonomic habits that protect surgeons' ...
An eye drop marketed as Clear Eyes Maximum Itchy Eye Relief (NDC: 67172-999-01 UPC 6 78112 65920 3) was recalled initially by the FDA on July 29, 2026, because of “lack of assurance of sterility.” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results